Immune Checkpoint Inhibitors Linked to Heart Inflammation
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, opening new horizons in the fight against malignancies by unleashing the immune system’s power to target tumor...
NEWS INDEX
Intrapartum Azithromycin’s Impact on Early Gut Mycobiota
The human gut is a complex ecosystem teeming not just with bacteria but also a diverse community of fungi, collectively known as the mycobiota. While...
DeepISLES: Clinically Validated Stroke Segmentation Model
In the rapidly evolving landscape of medical imaging and artificial intelligence, a groundbreaking advancement has emerged that promises to enhance the clinical management of ischemic...
Mitochondrial Metabolic Shifts Fuel Colorectal Cancer Resistance
In the relentless fight against colorectal cancer (CRC), researchers are unraveling intricate metabolic adaptations that tumors deploy to elude therapeutic destruction. Recent advances have spotlighted...
Cholesterol Balance Drives Recovery After Revascularization
In the evolving landscape of cardiovascular medicine, heart revascularization stands as a life-saving intervention aimed at restoring blood flow to ischemic myocardial tissue. This procedure,...
Circulating Hsp70 Signals Early Thoracic Cancer Spread
In the relentless search for reliable cancer biomarkers, a groundbreaking study has illuminated the role of circulating Heat Shock Protein 70 (Hsp70) as a pivotal...
Evolving Plasmodium falciparum Drug Resistance in Uganda
In a groundbreaking longitudinal study spanning half a decade, scientists have unveiled significant shifts in the susceptibility of Plasmodium falciparum—the deadliest malaria parasite species—to commonly...
Tanshinone IIA Boosts Olaparib Killing Breast Cancer Cells
In a promising advancement for breast cancer therapeutics, researchers have uncovered a potent synergy between Tanshinone IIA, a bioactive compound derived from traditional Chinese medicine,...
Resistance Exercise Boosts Sarcopenia in Breast Cancer
A groundbreaking new clinical trial is set to explore the therapeutic potential of resistance exercise in combating sarcopenia among breast cancer patients undergoing neoadjuvant chemotherapy....
Ligand Boosts Auranofin’s Cancer Therapy Effectiveness
The realm of cancer therapeutics is an ever-evolving landscape where the repurposing of existing drugs holds immense promise for accelerating treatment breakthroughs. Among such candidates,...
CDK1 & CDK2: Targets in Cancer Therapy
In the relentless pursuit of more effective cancer treatments, the intricate mechanisms governing cell division have consistently held the spotlight. Among the myriad of molecular...
Revolutionizing Pediatric Blunt Thoracic Trauma Imaging Techniques
In recent years, the field of pediatric radiology has witnessed significant advancements, particularly in the imaging of acute injuries sustained during blunt thoracic trauma. This...
Trial Tests Atezolizumab Plus Capecitabine in Triple-Negative Breast Cancer
A groundbreaking randomized phase II clinical trial, designated the MIRINAE trial (KCSG-BR18-21), has recently emerged from South Korea investigating innovative adjuvant therapies for one of...
ADAR1 RNA Editing: Breast Cancer’s Molecular Insights
In the rapidly evolving landscape of cancer research, the spotlight has recently turned toward a nuanced yet profoundly impactful molecular process: ADAR1-mediated RNA editing. This...
Comparing First-Line Treatments for Extensive-Stage SCLC
In a groundbreaking study published in BMC Cancer, researchers have conducted a multidimensional comparative evaluation of first-line therapies for extensive-stage small cell lung cancer (ES-SCLC),...
